News Banner

MaxQ News

MaxQ AI Continues to Deploy Intelligence-Based Clinical Technology

MaxQ Nov 18, 2018 5:29:00 PM

MaxQ AI Continues to Deploy Intelligence-Based Clinical Decision Support Technology Across the Healthcare Industry

CHICAGO, IL – November 28, 2017 – Today, MaxQ AI announced its third industry engagement to bring MaxQ AI’s A.I.-based clinical decision support application to imaging experts working in hospital emergency rooms and other acute care settings.

MaxQ AI Receives FDA Clearance for Accipio Ix™

MaxQ Nov 7, 2018 4:18:00 PM

FDA Clearance for Accipio Ix™ Intracranial Hemorrhage Platform

Agreement will pave the way for integration of MaxQ AI’s artificial intelligence Accipio Ix™ intracranial hemorrhage software into NeuroLogica’s medical imaging platforms in the U.S. and E.U. acute care market

Tel Aviv, Israel and Andover, MA – November 7, 2018 – MaxQ AI, a clinical diagnostics intelligence platform company, today announced that its revolutionary Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance paves the way for healthcare providers and physicians in acute care settings to have access to this artificial intelligence (AI) software designed to aid in prioritizing the clinical assessment of adult non-contrast head computed tomography (CT) cases that exhibit indications of intracranial hemorrhage (ICH), commonly known as a brain bleed.

MedyMatch Technology Announces Name Change to MaxQ AI

MaxQ Mar 18, 2018 4:47:00 PM
Tel Aviv, Israel March 18, 2018 – MedyMatch Technology, a company focused on assisting physicians provide accurate patient assessment through artificial intelligence-based insights, (which recently received FDA Breakthrough Designation for its intracranial hemorrhage (ICH) detection application), announced today an exciting new phase in its growth with the launch of its new corporate identity as MaxQ AI.

Samsung NeuroLogica and MedyMatch Alliance to Bring “A.I. to the Curbside”

MaxQ Mar 29, 2017 5:43:00 PM

Samsung NeuroLogica and MedyMatch Technology Announce Strategic Alliance to Bring “A.I. to the Curbside”

March 29, 2017 – Tel Aviv, Israel, and Danvers, MA – MedyMatch Technology, Ltd. and Samsung NeuroLogica Corporation, the healthcare subsidiary of Samsung Electronics Co., Ltd., today announced a collaboration to integrate artificial intelligence (A.I.) clinical decision support applications with Samsung NeuroLogica’s medical imaging hardware in the acute care marketplace. This collaboration will create support tools that provide a second read capability to help caregivers quickly and accurately assess patients in prehospital environments.

Approach for Cognitive Healthcare Decision Support

MaxQ Jan 24, 2017 6:00:00 PM


  • IBM Watson Health Imaging signs multiyear OEM agreement to license MaxQ AI’s patient specific - point of care – cognitive decision support algorithms.
  • The first application to be made available is MaxQ AI’s A.I. based intracranial hemorrhage detection.
  • Go-To-Market will focus on the delivery of cognitive based clinical decision support tools to service the acute care marketplace through IBM Watson Health Imaging.

Tel Aviv, Israel – January 24, 2017 – IBM (NYSE: IBM) and MaxQ AI announced today a multi-year, go to market relationship to deliver MaxQ AI’s cognitive-based clinical decision support algorithms to the acute care marketplace. The initial application, to be distributed through IBM Watson Health Imaging’s platform is MaxQ AI’s intracranial hemorrhage detection algorithm.

MedyMatch Reveals Artificial Intelligence Deep Vision

MaxQ Nov 22, 2016 6:21:00 PM

Intracranial Bleed Detection Technology

Tel Aviv, Israel – November 22, 2016 – MedyMatch Technology Ltd., (“MedyMatch”) the deep learning and artificial intelligence company, announced today that after several years of extensive research and development, it has achieved a major milestone in the availability, for research, of an artificial intelligence-based technology that can help detect the presence of intracranial hemorrhage or brain bleed which can occur in cases of brain trauma and stroke. Subtle bleeds are difficult to detect and if misinterpreted or missed by a physician can lead to serious patient injury and even death.

CIO Review Names MedyMatch in 100 Most Promising Big Data Solutions 2016

MaxQ Jul 21, 2016 6:46:00 PM
CIOReview has named MedyMatch one of the 100 most promising Big Data Solution Providers in 2016. Over 1,000 companies were considered for this honor.

Tel Aviv, Israel –July 21, 2016 – MedyMatch Technology Ltd., announced today that it has been ranked in the list of “100 Most Promising BigData Solution Providers” by CIOReview. A link to the article can be found here

MedyMatch Partners with Capital Health to Develop AI Platform

MaxQ Jun 27, 2016 6:34:00 PM

MedyMatch Partners with Capital Health to Develop Artificial Intelligence Platform for Emergency Rooms

Comprehensive Agreement Reached to Collaborate in Clinical Studies, A.I. Applications, and the Use of the Capital Health’s Extensive Medical Imaging and EMR Anonymized Patient Data Archives

Hopewell Township, NJ and Tel Aviv, Israel – June 27, 2016 – MedyMatch Technology Ltd., the data analytics healthcare company focused on providing physicians with artificial intelligence, real-time decision support tools in the emergency room, announced today a partnership with Capital Health, the first of several partnerships with hospitals in the United States intended to improve stroke patient outcomes. As part of the agreement, Capital Health will provide anonymized data to MedyMatch for use in the development of its first decision support tool, directed towards stroke patients.

MedyMatch to Present at Israeli Advanced Technology Industry’s BioMed Conference

MaxQ May 23, 2016 6:38:00 PM
Tel Aviv, Israel – May 23, 2016 – MedyMatch Technology Ltd., the data analytics healthcare company focused on providing physicians with artificial intelligence, real-time decision support tools in the emergency room, announced today that it has been selected to present at the 2016 Israeli Advanced Technology Industries (IATI) BioMed Conference.

Artificial intelligence healthcare startup MedyMatch launches

MaxQ Feb 17, 2016 5:47:00 PM


Former Philips Imaging Systems CEO Gene Saragnese Joins as Chairman & CEO

Boston, MA, and Tel Aviv, Israel – February 17, 2016 – MedyMatch Technology, Ltd., the artificial intelligence healthcare startup, announced today its launch and vision to improve performance in healthcare with real-time decision support tools, starting in the Emergency Room. Additionally, the Company announced that Mr. Gene Saragnese joined as Chairman & Chief Executive Officer.